Dr. Kendall E. Donaldson, MD

Dr. Donaldson practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Donaldson's NPI, 1013950237, was assigned on June 14, 2006. Dr. Donaldson graduated from University of Maryland School of Medicine - Baltimore in 1999. Dr. Donaldson holds Florida license ME87904.

Dr. Donaldson's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Donaldson's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Donaldson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Donaldson practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Donaldson's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Donaldson is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Donaldson is licensed in Florida.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Donaldson treats.

CMS data shows 2,013 Medicare services from Dr. Donaldson across 15 procedure codes in 2024, for 805 Medicare patients. Medicare paid $207,011 for them.

CMS counts 805 Medicare patients who saw Dr. Donaldson in 2024. The largest group is 75 to 84, with 365 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Donaldson's median patient age at 75, with 59% women.

In 2024, Dr. Donaldson wrote 3,309 Medicare Part D claims for 636 patients. 54% of them were for generic drugs. CMS names the drug for 3,187 of them, across 25 drugs with 11 or more claims each, at $351,768 in total drug cost. In 2023, CMS named 3,377 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Donaldson for performance year 2024, reported as part of a group. Dr. Donaldson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 304 procedures of cataract surgery by Dr. Donaldson, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Donaldson, published from 2006 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Visual Acuity, Phacoemulsification and Cataract. Dr. Donaldson has published most often in J Cataract Refract Surg. Dr. Donaldson's most frequent co-authors are Sonia H. Yoo, MD, Vasilios Frank Diakonis, MD and Florence Cabot, MD.

CMS Open Payments shows 732 general payments to Dr. Donaldson from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $101,305. It also lists 1 research payment totaling $4,375 in 2021.

Dmand AI lists 3 awards for Dr. Donaldson, most recently Regional Top Doctor in 2014.

Dr. Donaldson graduated from University of Maryland School of Medicine - Baltimore in 1999. Dr. Donaldson is a member of AAO.

Dr. Donaldson is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.